IMMVF (Immunovia AB) Cyclically Adjusted Book per Share: $0.68 (As of Mar. 2026)


IMMVF Immunovia AB IMMVF
44 GF Score
Price $0.02
GF Value $0.01
! 4 Warning Signs
View Full Analysis

What is Immunovia AB Cyclically Adjusted Book per Share?

Immunovia AB IMMVF -61.59% 44 Cyclically Adjusted Book per Share is $0.68 as of Mar. 2026. GuruFocus rates IMMVF with a GF Score™ of 44/100 and a GF Value™ of $0.01. The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Immunovia AB's adjusted book value per share for the three months ended in Mar. 2026 was $0.007. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $0.68 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Immunovia AB's average Cyclically Adjusted Book Growth Rate was -4.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-07-02), Immunovia AB's current stock price is $0.02. Immunovia AB's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was $0.68. Immunovia AB's Cyclically Adjusted PB Ratio of today is 0.03.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Immunovia AB was 0.09. The lowest was 0.03. And the median was 0.05.


Immunovia AB  (OTCPK:IMMVF) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Immunovia AB's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=0.02/0.68
=0.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Immunovia AB was 0.09. The lowest was 0.03. And the median was 0.05.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Immunovia AB Cyclically Adjusted Book per Share Related Terms


Immunovia AB Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Immunovia AB's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Immunovia AB Cyclically Adjusted Book per Share Chart

Immunovia AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.75 0.53

Immunovia AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.50 1.00 0.81 0.53 0.68

IMMVF vs TMO, DHR, IDXX: Cyclically Adjusted Book per Share Comparison

For the Diagnostics & Research subindustry, Immunovia AB's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Immunovia AB Cyclically Adjusted PB Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Immunovia AB's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Immunovia AB's Cyclically Adjusted PB Ratio falls into.


IMMVF
44GF Score
Immunovia AB IMMVF
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Immunovia AB Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Immunovia AB's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.007/133.3862*133.3862
=0.007

Current CPI (Mar. 2026) = 133.3862.

Immunovia AB Quarterly Data

Book Value per Share CPI Adj_Book
201606 0.238 101.019 0.314
201609 0.000 101.138 0.000
201612 0.641 102.022 0.838
201703 0.643 102.022 0.841
201706 0.636 102.752 0.826
201709 0.671 103.279 0.867
201712 0.584 103.793 0.751
201803 0.551 103.962 0.707
201806 1.052 104.875 1.338
201809 1.001 105.679 1.263
201812 0.939 105.912 1.183
201903 0.859 105.886 1.082
201906 0.790 106.742 0.987
201909 0.729 107.214 0.907
201912 0.691 107.766 0.855
202003 0.604 106.563 0.756
202006 1.139 107.498 1.413
202009 1.134 107.635 1.405
202012 1.135 108.296 1.398
202103 1.059 108.360 1.304
202106 0.989 108.928 1.211
202109 0.888 110.338 1.073
202112 0.756 112.486 0.896
202203 0.641 114.825 0.745
202206 0.535 118.384 0.603
202209 0.430 122.296 0.469
202212 0.372 126.365 0.393
202303 0.294 127.042 0.309
202306 0.104 129.407 0.107
202309 0.072 130.224 0.074
202312 0.056 131.912 0.057
202403 0.036 132.205 0.036
202406 0.016 132.716 0.016
202409 0.017 132.304 0.017
202412 0.005 132.987 0.005
202503 0.009 132.825 0.009
202506 0.005 133.699 0.005
202509 -0.002 133.482 -0.002
202512 0.010 133.386 0.010
202603 0.007 133.386 0.007

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of $0.68 mean?
Immunovia AB (IMMVF) has a Cyclically Adjusted Book per Share of $0.68 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Immunovia AB and its competitors.
Is Immunovia AB's Cyclically Adjusted Book per Share too high?
Immunovia AB's current Cyclically Adjusted Book per Share is $0.68. Overall, Immunovia AB has a GF Score™ of 44/100, reflecting its overall financial health beyond just this single metric.
How does Immunovia AB's Cyclically Adjusted Book per Share compare to TMO and DHR?
Immunovia AB's Cyclically Adjusted Book per Share of $0.68 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Medical Diagnostics & Research company?
A good Cyclically Adjusted Book per Share depends on the Medical Diagnostics & Research industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Immunovia AB and its competitors. Immunovia AB's current Cyclically Adjusted Book per Share is $0.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Immunovia AB stock overvalued right now?
Immunovia AB (IMMVF) has a current Cyclically Adjusted Book per Share of $0.68. The stock's GF Value™ is $0.01, compared to a current price of $0.02 — trading 100% above its estimated fair value. The current Cyclically Adjusted Book per Share is $0.68. Immunovia AB's overall GF Score™ is 44/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Immunovia AB (IMMVF), the current Cyclically Adjusted Book per Share is $0.68 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Immunovia AB (IMMVF) Overvalued in 2026?

Based on GuruFocus' analysis, Immunovia AB stock appears to be overvalued. The current stock price of $0.02 is trading 100% above its estimated GF Value™ of $0.01.

Key valuation signals for IMMVF:

  • Cyclically Adjusted Book per Share: $0.68
  • GF Value™: $0.01 vs. price of $0.02 (100% above fair value)
  • GF Score™: 44/100 with 4 warning signs

No single metric tells the full story. See the IMMVF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Immunovia AB Business Description

Other Exchanges IMMNOV:Sweden0G8X:UK
Address Scheelevagen 8, Medicon Village, Lund, SWE, 223 63
Immunovia AB is a diagnostic company. The company develops and commercializes diagnostic tools to detect proteins and autoimmune diseases. The company is developing its next-generation blood test to detect pancreatic cancer in high-risk individuals. IMMray platform is dedicated to the early detection of pancreatic cancer. Its technology platform IMMray (TM), is based on antibody microarray analysis.
44GF Score

Get the complete analysis for IMMVF

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.02
Price
$0.01
GF Value